The Japanese Ministry of Health, Labor and Welfare approved a glaucoma device made by Laguna Hills-based Glaukos Corp.
The iStent is inserted through a small corneal incision made during cataract surgery and is designed to provide sustained intraocular pressure reduction—a key symptom of glaucoma, which is a major cause of blindness. Glaukos, which is publicly traded, received Food and Drug Administration approval for iStent in 2012. It is now approved for sale in 27 countries.
—Vita Reed
